Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.
Lazzaroni F, Matera A, Marella A, Maeda A, Castellano G, Marchetti A, Fabris S, Pioggia S, Silvestris I, Ronchetti D, Lonati S, Fabbiano G, Traini V, Taiana E, Porretti L, Colombo F, De Magistris C, Scopetti M, Barbieri M, Pettine L, Torricelli F, Neri A, Passamonti F, Lionetti M, Da Vià MC, Bolli N. Lazzaroni F, et al. Among authors: barbieri m. Blood Adv. 2024 Aug 13;8(15):3972-3984. doi: 10.1182/bloodadvances.2023012409. Blood Adv. 2024. PMID: 38830132 Free PMC article.
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.
Lionetti M, Barbieri M, Todoerti K, Agnelli L, Marzorati S, Fabris S, Ciceri G, Galletti S, Milesi G, Manzoni M, Mazzoni M, Greco A, Tonon G, Musto P, Baldini L, Neri A. Lionetti M, et al. Among authors: barbieri m. Oncotarget. 2015 Sep 15;6(27):24205-17. doi: 10.18632/oncotarget.4434. Oncotarget. 2015. PMID: 26090869 Free PMC article.
Global methylation patterns in primary plasma cell leukemia.
Todoerti K, Calice G, Trino S, Simeon V, Lionetti M, Manzoni M, Fabris S, Barbieri M, Pompa A, Baldini L, Bollati V, Zoppoli P, Neri A, Musto P. Todoerti K, et al. Among authors: barbieri m. Leuk Res. 2018 Oct;73:95-102. doi: 10.1016/j.leukres.2018.09.007. Epub 2018 Sep 18. Leuk Res. 2018. PMID: 30257227
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma.
Taiana E, Favasuli V, Ronchetti D, Todoerti K, Pelizzoni F, Manzoni M, Barbieri M, Fabris S, Silvestris I, Gallo Cantafio ME, Platonova N, Zuccalà V, Maltese L, Soncini D, Ruberti S, Cea M, Chiaramonte R, Amodio N, Tassone P, Agnelli L, Neri A. Taiana E, et al. Among authors: barbieri m. Leukemia. 2020 Jan;34(1):234-244. doi: 10.1038/s41375-019-0542-5. Epub 2019 Aug 19. Leukemia. 2020. PMID: 31427718
Compendium of FAM46C gene mutations in plasma cell dyscrasias.
Barbieri M, Manzoni M, Fabris S, Ciceri G, Todoerti K, Simeon V, Musto P, Cortelezzi A, Baldini L, Neri A, Lionetti M. Barbieri M, et al. Br J Haematol. 2016 Aug;174(4):642-5. doi: 10.1111/bjh.13793. Epub 2015 Oct 12. Br J Haematol. 2016. PMID: 26456599 Free article. No abstract available.
Primary plasma cell leukemia 2.0: advances in biology and clinical management.
Neri A, Todoerti K, Lionetti M, Simeon V, Barbieri M, Nozza F, Vona G, Pompa A, Baldini L, Musto P. Neri A, et al. Among authors: barbieri m. Expert Rev Hematol. 2016 Nov;9(11):1063-1073. doi: 10.1080/17474086.2016.1244002. Epub 2016 Oct 24. Expert Rev Hematol. 2016. PMID: 27759436 Review.
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients.
Lionetti M, Barbieri M, Favasuli V, Taiana E, Fabris S, Favoino C, Ciceri G, Matis S, Colombo M, Massara R, Reda G, Gentile M, Spina V, Rossi D, Baldini L, Gaidano G, Fais F, Ferrarini M, Morabito F, Cutrona G, Neri A. Lionetti M, et al. Among authors: barbieri m. Hematol Oncol. 2020 Aug;38(3):406-408. doi: 10.1002/hon.2722. Epub 2020 Feb 25. Hematol Oncol. 2020. PMID: 32097987 No abstract available.
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance.
Colombo M, Garavelli S, Mazzola M, Platonova N, Giannandrea D, Colella R, Apicella L, Lancellotti M, Lesma E, Ancona S, Palano MT, Barbieri M, Taiana E, Lazzari E, Basile A, Turrini M, Pistocchi A, Neri A, Chiaramonte R. Colombo M, et al. Among authors: barbieri m. Haematologica. 2020 Jul;105(7):1925-1936. doi: 10.3324/haematol.2019.221077. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582544 Free PMC article.
1,164 results